Archives
-
1-methyl Adenosine Assay Workflows
2026-09-11
Build reliable 1-methyl Adenosine workflows for cell perturbation, intracellular nucleoside profiling, and biomarker discovery. The practical strategy combines controlled dosing with stable isotope-diluted UHPLC–MS/MS, chromatographic isomer separation, and matrix cleanup.
-
MK-571 Workflows for Inflammation Research
2026-09-11
MK-571 (L-660,711) helps separate cysteinyl leukotriene signaling from ABCC1/MRP1-linked drug transport in airway and macrophage assays. This practical guide covers assay setup, dosing logic, cross-model controls, and troubleshooting for bronchoconstriction, allergic inflammation, and chemotherapy-stress workflows.
-
RSL3 Workflows for GPX4-Driven Ferroptosis
2026-09-10
RSL3 provides a fast, mechanistically focused way to test GPX4-dependent ferroptosis, from HCC pathway studies to RAS-driven cancer models. This guide combines practical handling, quantitative assay conditions, TEAD2-informed experimental design, and troubleshooting for more reproducible oxidative cell-death results.
-
Schizophrenia Risk Pathways in Developing Neurons
2026-09-10
Liu et al. used cell-type-resolved human iPSC models to show that schizophrenia-associated loci converge on different developmental pathways in cortical interneurons and glutamatergic neurons. The study links interneuron risk loci to PKC hyperactivity and arborization defects, while glutamatergic-neuron loci affect ion transport and calcium currents, providing a framework for cell-specific mechanistic studies.
-
Amiloride (MK-870) for Ion Transport Workflows
2026-09-09
Amiloride (MK-870) enables controlled perturbation of epithelial sodium transport, with practical value in sodium channel research, cystic fibrosis research, and hypertension research. Its negative result in a reovirus-entry study also makes it a useful specificity control when testing cellular endocytosis modulation rather than a presumed universal uptake inhibitor.
-
SM-164: Reliable Apoptosis Assay Workflows
2026-09-09
This scenario-based guide explains how SM-164 (SKU A8815), a bivalent Smac mimetic, can support interpretable viability, proliferation, and apoptosis experiments. It covers mechanism, solvent compatibility, handling, orthogonal readouts, and practical criteria for selecting a reliable research reagent.
-
Sinapine Targets PLCβ3 EF Hands in Cardiovascular Disease
2026-09-08
The reference study identifies the PLCβ3 EF-hand domain, particularly Asn-260, as a druggable site for disrupting the Gαq–PLCβ3 interaction in RAAS-driven cardiovascular disease. By combining chemical-probe target identification, biochemical validation, and aldosteronism and hypertension models, the authors position sinapine as a more pathway-focused alternative to broad Gαq or PLC inhibition.
-
Primidone (Mysoline) for TRPM3 and RIPK1 Research
2026-09-08
Primidone, also known as Mysoline, gives researchers a practical bridge between TRPM3 channel pharmacology, RIPK1 signaling, and translational disease models. This guide covers assay setup, concentration selection, animal-study context, CYP19 counter-screening, and troubleshooting for reproducible workflows.
-
Silymarin: Silybin A Workflow for Liver Research
2026-09-07
Build reproducible Silybin A experiments around solubility control, orthogonal viability and motility assays, and pathway-aware validation. This workflow distinguishes purified Silybin A from Silymarin mixtures while adapting a hepatocellular carcinoma metastasis assay framework without overstating evidence.
-
O6-Benzylguanine MGMT Inhibitor Workflows
2026-09-07
Use O6-Benzylguanine to separate MGMT-dependent DNA repair from broader transcriptional resistance mechanisms and to design stronger alkylator-sensitization experiments. This practical workflow connects stock preparation, combination assays, DNA-damage readouts, and the AP-2α–MGMT findings in recurrent glioblastoma research.
-
Erastin Workflow for Ferroptosis Research
2026-09-05
Build reproducible ferroptosis assays with Erastin by controlling DMSO handling, cell density, exposure time, and orthogonal oxidative-stress readouts. The workflow also connects RAS/BRAF genotype, system Xc⁻ activity, and PERK–SLC7A11 biology to practical cancer biology research decisions.
-
GSK3 Inhibition Controls M. tuberculosis Infection
2026-09-04
The 2024 iScience study identifies glycogen synthase kinase 3 as a host pathway that supports intracellular Mycobacterium tuberculosis growth in macrophages. Through phenotypic screening, genetic validation, and phospho-proteomic analysis, the authors show that GSK3 inhibition promotes an antimicrobial macrophage state and provides a mechanistic basis for host-directed tuberculosis therapy.
-
TH287 MTH1 Inhibitor for Cancer Radiosensitization
2026-09-04
TH287 converts oxidized nucleotide stress into a measurable DNA-damage phenotype and offers a practical route to studying cancer cell selective cytotoxicity. In castration-resistant prostate cancer models, schedule-dependent combination with ionizing radiation provides a focused workflow for testing radiosensitization, apoptosis, and cell-cycle disruption.
-
Ricin Bystander Necroptosis in Lung Epithelium
2026-09-03
Kempen and colleagues show that ricin-injured monocytic cells can transmit a soluble death signal to lung epithelial cells, converting direct toxin injury into bystander necroptosis. The study identifies released ricin, Fas ligand, and HMGB1–RAGE-associated reactive oxygen species as important components of this process, providing a mechanistic framework for inflammatory amplification during ricin-induced lung damage.
-
Primidone (Mysoline): Mechanisms and Research Use
2026-09-03
Primidone (Mysoline) is an established anticonvulsant with experimentally defined activity at TRPM3 and RIPK1. Its research value spans TRPM3 channel inhibition in neurodevelopmental disorders, RIPK1 inhibition in neurodegenerative disease models, and disease-specific animal studies, but these applications remain distinct from approved clinical indications.